Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 11:56 am Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | Woodline Partners LP | 6,029,906 5.600% | 6,029,906 (New Position) | Filing History |
| 2025-08-13 5:00 pm Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | Farallon Capital Partners, L.P. | 9,157,000 8.400% | 1,975,000 (+27.50%) | Filing History |
| 2025-08-12 09:06 am Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | Adage Capital Management, L.P. | 5,905,349 5.450% | 5,905,349 (New Position) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | BlackRock Inc. BLK | 5,457,030 5.000% | 5,457,030 (New Position) | Filing History |
| 2025-06-13 5:25 pm Purchase | 2025-06-06 | 13G | Tango Therapeutics, Inc. TNGX | Farallon Capital Partners, L.P. | 7,182,000 6.600% | 7,182,000 (New Position) | Filing History |
| 2025-02-14 12:33 pm Sale | 2024-12-31 | 13G | Tango Therapeutics, Inc. TNGX | EcoR1 Capital, LLC | 10,630,736 9.900% | -2,700,000 (-20.25%) | Filing History |
| 2025-01-02 07:07 am Sale | 2024-12-30 | 13D | Tango Therapeutics, Inc. TNGX | BCTG Holdings, LLC | 10,740,385 10.000% | -4,473,668 (-29.40%) | Filing History |
| 2024-12-06 11:14 am Sale | 2024-11-29 | 13G | Tango Therapeutics, Inc. TNGX | FMR LLC | 13,392 0.000% | -9,773,958 (-99.86%) | Filing History |
| 2024-11-20 4:24 pm Purchase | 2024-11-13 | 13G | Tango Therapeutics, Inc. TNGX | TCG Crossover GP II, LLC | 10,500,612 9.800% | 10,500,612 (New Position) | Filing History |
| 2024-11-07 9:35 pm Unchanged | 2024-11-06 | 13D | Tango Therapeutics, Inc. TNGX | Boxer Capital Management LLC | 6,988,450 6.500% | 0 (Unchanged) | Filing History |
| 2024-10-28 09:22 am Purchase | 2024-10-25 | 13D | Tango Therapeutics, Inc. TNGX | Boxer Capital Management LLC | 6,988,450 6.500% | 6,988,450 (New Position) | Filing History |
| 2024-10-15 9:40 pm Purchase | 2024-10-10 | 13D | Tango Therapeutics, Inc. TNGX | Boxer Capital LLC | 8,339,935 7.800% | 8,339,935 (New Position) | Filing History |
| 2024-10-15 7:25 pm Purchase | 2024-10-10 | 13D | Tango Therapeutics, Inc. TNGX | Boxer Asset Management Inc. | 26,961 0.100% | 26,961 (New Position) | Filing History |
| 2024-09-04 8:45 pm Sale | 2024-08-30 | 13D | Tango Therapeutics, Inc. TNGX | Third Rock Ventures IV L.P. | 17,001,475 15.900% | -2,362,500 (-12.20%) | Filing History |
| 2024-04-08 08:46 am Unchanged | 2024-04-08 | 13G | Tango Therapeutics, Inc. TNGX | Southpoint Capital Advisors LP | 5,276,699 4.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX | Southpoint Capital Advisors LP | 5,276,699 5.200% | 776,699 (+17.26%) | Filing History |
| 2024-02-13 4:51 pm Unchanged | 2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 4.800% | 0 (Unchanged) | Filing History |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Tango Therapeutics, Inc. TNGX | FMR LLC | 9,787,350 9.596% | -3,760,722 (-27.76%) | Filing History |
| 2023-10-18 5:23 pm Purchase | 2023-10-16 | 13D | Tango Therapeutics, Inc. TNGX | BCTG Holdings, LLC | 15,214,053 15.000% | 1,075,000 (+7.60%) | Filing History |
| 2023-10-16 3:33 pm Purchase | 2023-10-13 | 13G | Tango Therapeutics, Inc. TNGX | EcoR1 Capital, LLC | 13,330,736 13.100% | 5,503,100 (+70.30%) | Filing History |